Influenza Diagnostic Market Is Likely To Be Influenced By Emergence Of Technologically Advanced Influenza Diagnostics Tests Till 2024: Grand View Research, Inc.
The influenza diagnostics market is expected to reach
USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc.
Influenza, or "the flu," is an infectious disease and affects the
upper respiratory tract in humans. The disease is common in children and
elderly population (aged 65 years and above). The disease has a huge impact on
public health. Influenza A virus poses a greater risk as compared to the
influenza B virus. The B virus is responsible for 20% to 25% of infections
globally. The growth in the influenza diagnostic market is attributed to factors
such as emergence of technologically advanced diagnostic tests with shorter
turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal
influenza vaccination for prevention and control of seasonal influenza; and the
demand created for influenza diagnosis in the flu season.
Global Influenza Diagnostics Market, 2014 - 2024 (USD Million) |
Rapid
Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015.
RIDTs are tests that deliver accurate results in approximately 15 minutes. This
factor deems them efficient, which has resulted in the lucrative growth of this
segment with the fastest CAGR. Reverse transcription polymerase chain reaction
(RT-PCR) holds the second highest market share following RIDTs, and this can be
attributed to the fact that it provides detailed analytical results, sharper turnaround
times, and high throughput.
Hospitals
held the highest market share in 2015, but Point-of-Care Testing (POCT) is
anticipated to overtake and lead the market in the coming future, owing to the
increasing usage of POCT because of its ease of use and short turnaround times.
North
America dominates the market, due to a high focus of the government and
healthcare bodies to control influenza.
Browse full
research report on Influenza Diagnostic Market: www.grandviewresearch.com/industry-analysis/influenza-diagnostics-market
Further key
findings from the report suggest:
- North
America is anticipated to dominate the global influenza diagnostics
market. The high adoption rates of in vitro diagnostics and presence of
technologically advanced medical devices is expected to drive growth in
the region.
- The
Asia Pacific region is anticipated to be the fastest growing region in the
study period. This growth is attributed to factors such as increasing
initiatives by the countries to counter the incidence of the disease. For
instance, CDC reached a cooperative agreement with South-East Asian Region
to fund non research-related bilateral influenza as a measure to respond
to avian, seasonal, and pandemic influenza.
- The
RIDT segment is expected to grow at a significant rate compared to others
and accounts for the largest share in 2015.
- This
market comprises several local as well as global players. Some of the
major players of this vertical include Becton, Dickinson and Company,
Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher
Scientific.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the influenza diagnostics market on the
basis of test type, end use, and region:
Test Type
Outlook (Revenue, USD Million, 2013 - 2024)
- RIDTs
- RT-PCR
- Cell
Culture
- Others
End-use
Outlook (Revenue, USD Million, 2013 - 2024)
- Hospital
- Point-of-Care
Testing
- Laboratories
Regional
Outlook (Revenue, USD Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Saudi
Arabia
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-influenza-diagnostics-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment